Browsing by Author Wei, Andrew

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
or enter first few letters:  
Showing results 1 to 3 of 3
Issue DateTitleAuthor(s)Citation
2014Have all-trans retinoic acid and arsenic trioxide replaced all-trans retinoic acid and anthracyclines in APL as standard of care.Iland, Harry; Seymour, John F.; Wei, Andrew; Central Clinical School: MedicineHave all-trans retinoic acid and arsenic trioxide replaced all-trans retinoic acid and anthracyclines in APL as standard of care., Best Practice & Research: Clinical Haematology, vol.27, 1, 2014,pp 39-52
2015Maintenance lenalidomide in combination with 5-azacitidine as post-remission therapy for acute myeloid leukaemiaStevenson, William; Avery, S; Fleming, Shaun; Govindaraj, Chindu; Macmanus, Julie; Patil, S; Perruzza, Sarah; Plebanski, Magdalena; Spencer, Andrew; Tan, Peter; Wei, Andrew; Northern Clinical School: MedicineMaintenance lenalidomide in combination with 5-azacitidine as post-remission therapy for acute myeloid leukaemia, British Journal of Haematology, vol.169, 2, 2015,pp 199-210
2014Optimal approach for high-risk acute promyelocytic leukemiaIland, Harry; Seymour, John F.; Wei, Andrew; Central Clinical School: MedicineOptimal approach for high-risk acute promyelocytic leukemia, Current Opinion In Hematology, vol.21, 4, 2014,pp 102-113